Nanobiotix S.A. ADR (NBTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2022 | 06-2022 | 12-2021 | 06-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -60,098 | -28,049 | -55,609 | -36,653 | -38,370 |
| Depreciation Amortization | 1,580 | 794 | 1,846 | 965 | 2,004 |
| Other Working Capital | 2,422 | 4,168 | 13,653 | 11,571 | 6,581 |
| Other Operating Activity | 17,003 | 4,444 | 4,768 | 5,958 | -1,672 |
| Operating Cash Flow | $-39,093 | $-18,643 | $-35,342 | $-18,159 | $-31,457 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -97 | -84 | -270 | -54 | -110 |
| Other Investing Activity | 242 | 141 | -16 | -6 | -18 |
| Investing Cash Flow | $145 | $56 | $-286 | $-60 | $-128 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -5,954 | -3,731 | -6,128 | -2,052 | 127,674 |
| Financing Cash Flow | $-5,954 | $-3,731 | $-6,128 | $-2,052 | $127,674 |
| Exchange Rate Effect | 87 | 76 | 76 | 10 | -72 |
| Beginning Cash Position | 88,419 | 89,309 | 140,968 | 143,565 | 40,088 |
| End Cash Position | 43,606 | 67,067 | 99,287 | 123,305 | 136,106 |
| Net Cash Flow | $-44,813 | $-22,242 | $-41,681 | $-20,259 | $96,017 |
| Free Cash Flow | |||||
| Operating Cash Flow | -39,093 | -18,643 | -35,342 | -18,159 | -31,457 |
| Free Cash Flow | -39,093 | -18,643 | -35,342 | -18,159 | -31,457 |